579 related articles for article (PubMed ID: 2670032)
1. The linear-quadratic formula and progress in fractionated radiotherapy.
Fowler JF
Br J Radiol; 1989 Aug; 62(740):679-94. PubMed ID: 2670032
[No Abstract] [Full Text] [Related]
2. Survival curve description for fractionated radiation therapy.
Kozubek S
Neoplasma; 1982; 29(2):135-48. PubMed ID: 7110444
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of the biological efficacy of fractionated HDR (high dose rate)-afterloading using the linear-quadratic equation].
Glaser FH; Möldner B
Radiobiol Radiother (Berl); 1989; 30(4):305-9. PubMed ID: 2798789
[No Abstract] [Full Text] [Related]
4. [The Fowler model, a practical alternative between the Ellis formula and the Cohen model].
Franke DS
Radiobiol Radiother (Berl); 1988; 29(1):69-76. PubMed ID: 3387537
[No Abstract] [Full Text] [Related]
5. Some aspects of the chronological dose distribution in the radiobiology and radiotherapy.
Ulmer W
Strahlenther Onkol; 1986 Jun; 162(6):374-86. PubMed ID: 3738738
[TBL] [Abstract][Full Text] [Related]
6. Reoxygenation of hypoxic tumour cells.
van Putten LM
Strahlentherapie; 1977 Jun; 153(6):380-3. PubMed ID: 877974
[TBL] [Abstract][Full Text] [Related]
7. Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula.
Barton M
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):371-8. PubMed ID: 7836091
[TBL] [Abstract][Full Text] [Related]
8. Quantitative aspects of normal tissue damage tolerance for megavoltage irradiation in hyperbaric oxygen.
Van Den Brenk HA
Nunt Radiol; 1968 Jan; 34(1):69-78. PubMed ID: 5717163
[No Abstract] [Full Text] [Related]
9. [Optimization of fractionated radiotherapy of tumors].
Ivanov VK
Radiobiol Radiother (Berl); 1984; 25(5):691-7. PubMed ID: 6548824
[No Abstract] [Full Text] [Related]
10. Letter: Formulas for the calculation of the total dose in fractionated radiotherapy.
Jones D
Cancer Res; 1973 Nov; 33(11):3051. PubMed ID: 4748454
[No Abstract] [Full Text] [Related]
11. [Dose-time optimization in fractionated radiotherapy].
Kriester A; Kloetzer KH; Kob D
Strahlenther Onkol; 1988 Aug; 164(8):489-98. PubMed ID: 3138769
[TBL] [Abstract][Full Text] [Related]
12. Radiobiological data on time-dose relationships.
Fowler JF
Radiol Clin Biol; 1973; 42(1):1-15. PubMed ID: 4574016
[No Abstract] [Full Text] [Related]
13. [Radiobiological research. A basis for advances in clinical radio-oncology].
Dubben HH; Beck-Bornholdt HP; Hübener KH
Rontgenpraxis; 1992 Sep; 45(9):309-16. PubMed ID: 1440068
[No Abstract] [Full Text] [Related]
14. Experimental results and clinical implications of the four R's in fractionated radiotherapy.
Trott KR
Radiat Environ Biophys; 1982; 20(3):159-70. PubMed ID: 7051129
[TBL] [Abstract][Full Text] [Related]
15. Independent process inactivation of irradiated tumor cells in vivo.
Maruyama Y; Ackerman E; Khan FM
Radiology; 1970 May; 95(2):421-3. PubMed ID: 5439453
[No Abstract] [Full Text] [Related]
16. Hypoxia as a determinant factor in radiotherapy? Where are we?
Guichard M
BJR Suppl; 1992; 24():142-5. PubMed ID: 1290689
[No Abstract] [Full Text] [Related]
17. Radiation biology at clinically relevant fractions.
Peters LJ; Brock WA; Travis EL
Important Adv Oncol; 1990; ():65-83. PubMed ID: 2182524
[No Abstract] [Full Text] [Related]
18. [Problems concerning fractionated radiotherapy (2). Time-dosage distribution in relation to the repair of potentially lethal damage and repopuration of cancer cells].
Urano M
Rinsho Hoshasen; 1976 Oct; 21(11):1015-6. PubMed ID: 1034060
[No Abstract] [Full Text] [Related]
19. Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.
Sheldon PW; Fowler JF
Br J Cancer Suppl; 1978 Jun; 3():242-5. PubMed ID: 277239
[TBL] [Abstract][Full Text] [Related]
20. [Cancer and radiotherapy(3). Radiobiology for radiotherapy].
Ando K
Iyodenshi To Seitai Kogaku; 1982 Apr; 20(2):122-9. PubMed ID: 6752496
[No Abstract] [Full Text] [Related]
[Next] [New Search]
